Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

NCT05908071 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1200

Enrollment

NETWORK

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SHEN26 capsule
DRUG: SHEN26 placebo

Sponsor

Shenzhen Kexing Pharmaceutical Co., Ltd.